Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating activities:
Net loss	$ (173,799)	$ (18,916)
Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation expense	1,531	1,325
Stock-based compensation expense	2,610	2,893
Change in fair value of the Convertible Loan	120,963	(31,399)
Non-cash interest expense	16,568	10,758
Gain on debt and Convertible Loan extinguishments		(2,166)
Impairment expense	5,412
Change in right-of-use asset	2,364	2,053
Changes in operating assets and liabilities:
Prepaid expenses and other assets	39	5,106
Accounts payable and accrued liabilities	(334)	(3,755)
Accrued compensation	(89)	1,512
Operating lease liability	(1,028)	(4,962)
Net cash used in operating activities	(25,763)	(37,551)
Investing activities:
Purchases of property and equipment	(542)	(1,879)
Net cash used in investing activities	(542)	(1,879)
Financing activities:
Proceeds from issuance of term debt, net of issuance costs	25,000	34,889
Payments for taxes related to net share settlement of equity awards	(46)	(61)
Proceeds from exercise of stock options	658	130
Net cash provided by financing activities	25,612	34,958
Net change in cash, cash equivalents and restricted cash	(693)	(4,472)
Cash, cash equivalents and restricted cash, beginning of period	14,771	19,243
Cash, cash equivalents and restricted cash, end of period	$ 14,078	14,771
Supplemental disclosure of cash flow information:
Right-of-use asset obtained by assuming operating lease liabilities		$ 977